Skip to main content
. 2006 Aug 29;95(6):691–698. doi: 10.1038/sj.bjc.6603327

Table 3. Response to immunotherapy stratified according to risk group (P=0.001).

  CR, PR
SD
PD
  n % n % n %
Low risk, n=32 8 66.7 15 46.9 9 18.4
Medium, risk n=32 4 33.3 16 50.0 12 24.5
High risk, n=29 0 0 1 3.1 28 57.1

CR=complete relapse; PD=progressive disease; PR=partial relapse; SD=stable disease.